Science Explorer Interactive view Map
Company · Levallois-Perret · France

Alexion Pharmaceuticals (France)

alexion.com/SelectCountry/France.aspxROR OpenAlex
Research works
18
▲ 379% vs 2013–17
Citations
617
33.8 per fractional work
Top-10% rate
1.5%
record average 16.5%
Open access
21%
world 28%

Not ranked overall: Alexion Pharmaceuticals (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.15× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.66× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.61× its world share, 0 worksImmunology and Micro…Health Professions: 0.23× its world share, 0 worksHealth ProfessionsMedicine: 3.95× its world share, 4 worksMedicineEconomics, Econometrics and Finance: 0.49× its world share, 0 worksEconomics, Econometr…Psychology: 0.55× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

Which research topics does Alexion Pharmaceuticals (France) publish most on?

By volume in 2022–2025: Myasthenia Gravis and Thymoma, Cancer Treatment and Pharmacology, Peripheral Neuropathies and Disorders and Parkinson's Disease and Spinal Disorders.

Myasthenia Gravis and Thymoma: 1 fractional worksCancer Treatment and Pharmacology: 1 fractional worksPeripheral Neuropathies and Disorders: 1 fractional worksParkinson's Disease and Spinal Disorders: 0 fractional worksProtein Tyrosine Phosphatases: 0 fractional worksAmyloidosis: Diagnosis, …0Amyloidosis: Diagnosis, Treatment, Outcomes: 0 fractional worksRetinal Diseases and Treatments: 0 fractional worksSphingolipid Metabolism and Signaling: 0 fractional worksLysosomal Storage Disorders Research: 0 fractional worksThyroid and Parathyroid Surgery: 0 fractional works
NeurologyOncologyMolecular BiologyOphthalmology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Myasthenia Gravis and Thymoma Neurology 1 works
  2. 2 Cancer Treatment and Pharmacology Oncology 1 works
  3. 3 Peripheral Neuropathies and Disorders Neurology 1 works
  4. 4 Parkinson's Disease and Spinal Disorders Neurology 0 works
  5. 5 Protein Tyrosine Phosphatases Molecular Biology 0 works
  6. 6 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 0 works
  7. 7 Retinal Diseases and Treatments Ophthalmology 0 works
  8. 8 Sphingolipid Metabolism and Signaling Molecular Biology 0 works
  9. 9 Lysosomal Storage Disorders Research Physiology 0 works
  10. 10 Thyroid and Parathyroid Surgery Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available21.2%not open78.8%

World: 28% of research is openly available.

with international co-authors34.7%domestic only65.3%

World: 19% is written across borders.

How has Alexion Pharmaceuticals (France)'s research output changed?

Output in 2018–2022 was 379% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Levallois-Perret

All research institutions in Levallois-Perret

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.